000 | 01928 a2200505 4500 | ||
---|---|---|---|
005 | 20250516202837.0 | ||
264 | 0 | _c20150410 | |
008 | 201504s 0 0 eng d | ||
022 | _a1879-0844 | ||
024 | 7 |
_a10.1002/ejhf.62 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTarone, Guido | |
245 | 0 | 0 |
_aTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. _h[electronic resource] |
260 |
_bEuropean journal of heart failure _cMay 2014 |
||
300 |
_a494-508 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCyclosporine _xpharmacology |
650 | 0 | 4 |
_aDrugs, Investigational _xpharmacology |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xdrug therapy |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aMyocytes, Cardiac _xmetabolism |
650 | 0 | 4 |
_aSarcoplasmic Reticulum Calcium-Transporting ATPases _xpharmacology |
650 | 0 | 4 | _aTranslational Research, Biomedical |
650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
700 | 1 | _aBalligand, Jean-Luc | |
700 | 1 | _aBauersachs, Johann | |
700 | 1 | _aClerk, Angela | |
700 | 1 | _aDe Windt, Leon | |
700 | 1 | _aHeymans, Stephane | |
700 | 1 | _aHilfiker-Kleiner, Denise | |
700 | 1 | _aHirsch, Emilio | |
700 | 1 | _aIaccarino, Guido | |
700 | 1 | _aKnöll, Ralph | |
700 | 1 | _aLeite-Moreira, Adelino F | |
700 | 1 | _aLourenço, André P | |
700 | 1 | _aMayr, Manuel | |
700 | 1 | _aThum, Thomas | |
700 | 1 | _aTocchetti, Carlo G | |
773 | 0 |
_tEuropean journal of heart failure _gvol. 16 _gno. 5 _gp. 494-508 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ejhf.62 _zAvailable from publisher's website |
999 |
_c23649170 _d23649170 |